Orexo and ProStrakan extend licensing agreement for pain drug
This change of partner in North America follows the decision made by Endo Pharmaceuticals Holdings following its own internal strategy changes to return all rights for Rapinyl (Abstral)
The US Food and Drug Administration (FDA) has granted rare paediatric disease designation to Vanda Pharmaceuticals’ VCA-894A, an investigational antisense oligonucleotide therapy for Charcot-Marie-Tooth disease, axonal, type 2S (CMT2S).
Mount Desert Island Biological Laboratory’s (MDI) comparative toxicogenomics database (CTD) is a valuable, manually curated resource, which advances understanding the effects of environmental chemicals on human health. Biomax